LINC01243

Across TCGA pan-cancer cohorts, LINC01243 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01243 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher LINC01243 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01243 expression acts as an unfavorable survival marker.

PAAD, LIHC, and ESCA are the cancer types where LINC01243 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.132	0.590	<.001	45	view →
LIHC	OS	Tertile	III,IV	0.270	0.679	<.001	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRP	DFS	Tertile	II,III,IV	0.212	0.781	.002	36	view →
HNSC	OS	Tertile	All	0.194	0.617	<.001	36	view →
PCPG	OS	Tertile	All	0.412	0.970	<.001	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
COAD	DFS	Tertile	III,IV	0.189	0.565	.016	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
LUSC	OS	Tertile	All	0.588	0.828	.012	18	view →
SKCM	OS	Tertile	IV	0.133	0.621	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01243–PAAD (OS)

Open the PAAD breakdown →